Ichikawa, Japan

Norio Ohto


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Kanagawa, JP (1990)
  • Ichikawa, JP (1991 - 1992)
  • Chiba, JP (1994 - 1996)
  • Chiba-ken, JP (1996 - 1997)

Company Filing History:


Years Active: 1990-1997

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Norio Ohto: Innovator in Pharmaceutical Chemistry

Introduction

Norio Ohto is a prominent inventor based in Ichikawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 7 patents to his name, Ohto's work has had a substantial impact on the medical community.

Latest Patents

Ohto's latest patents include innovative compounds such as aminoketone derivatives, which are useful as effective ingredients in centrally acting muscle relaxants and agents for curing pollakiurea. One notable compound is (+)3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl] isoxazole, which exhibits remarkable central muscle relaxant action compared to its racemic modification. This compound can be effectively separated from its racemic form using optically active 10-camphorsulfonic acid for optical resolution. Additionally, he has developed pyrrolidinone derivatives that serve as antipsychotics and therapeutics for ischemic cerebral diseases, which do not induce extrapyramidal side effects.

Career Highlights

Ohto is currently associated with Mitsui Toatsu Chemicals, Incorporated, where he continues to innovate and contribute to the field. His work has been recognized for its potential to improve patient outcomes through the development of safer and more effective medications.

Collaborations

Ohto has collaborated with notable colleagues such as Seitaro Kajiya and Hajime Iizuka, further enhancing the scope and impact of his research.

Conclusion

Norio Ohto's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing new therapeutic agents. His patents reflect a commitment to improving healthcare through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…